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19th CardioVascular Summit: TCTAP 201421.0 min) were found between the TRI and TFI groups. The 30-day survival rate was
38% in all patients, 31% in the TRI group, and 43% in the TFI group.
Conclusion: The present study demonstrates that when performed by a skilled operator,
TRI is equally feasible as TFI for patients with AMI complicated by cardiac arrest.
TCTAP A-124
A Reliable and Secure Non-pharmacological Way of Preventing Radial Artery
Spasm in Transradial Intervention
Andy Wai Kwong Chan
Andy Wai Kwong Chan Heart Centre, Hong Kong, Hong Kong, China
Background: Radial artery spasm (RAS) is one of themain reasons causing failure and/or
complication of trans-radial intervention (TRI). Causes of spasm include anxious/sensitive
patient, small radial artery size, frequent catheter passage especially guiding catheter with
relative blunt tip. RAS usually resolves with intra-arterial vasodilator, sedation and/or
analgesics but sometimes persists despite all kinds of treatment. Since brachial artery spasm
rarely occurs and initial entry of radial sheath with the assistance of the tapered dilator is
usually easy, use of long radial sheath up to distal brachial artery should avoid RAS.
Methods: The experience of using 6F 25cm long radial sheath (St Jude Engage TR
sheath) by a single operator at a single cardiac catheterization laboratory (CCL) from
mid June to October 2013 was reported.
Results: There was a total of 41 coronary procedures done by the author at that
CCL during that period. There were 33 coronary angiogram (CA) proceeding to
percutaneous coronary intervention (PCI), 5 CA with intravascular ultrasound but not
PCI, and 3 CA only. There were 30 males and 11 females, with average age of
62.7 years old and body weight of 67.6 kg. All CA or/and PCI were successfully done
trans-radially using the 6F 25cm long radial sheath except in two patients in whom a
6F 10cm Terumo radial sheath was used instead due to the course of the 0.025 inch
radial sheath guidewire was considered not entirely satisfactory. No switch over to
trans-femoral route was needed. No RAS was noted. No injection of vasodilator/
sedation/ analgesics was needed except for one patient who had mild spasm of distal
brachial artery after the 0.035 inch guidewire passing through the loop and straight-
ening the loop at that distal bradial artery. The spasm was promptly resolved with
intra-arterial 200ug nitroglycerin. At the end of the procedures, all the sheaths were
successfully removed without difﬁculty or complication. TR bands were used for
haemostasis. All patients were discharged the next morning. No major adverse cardiac
event or vascular complication was noted during hospitalization and clinic follow-up
within a week after procedure.
Conclusion: TRI using long radial sheath up to distal brachial artery eliminated RAS,
and appeared safe. A larger scale, prospective randomized trial of long versus ordinary
radial sheath in TRI may be warranted.
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TCTAP A-125
A Comparison of Post Implant Aortic Valve Gradient of Transcatheter and
Surgical Tissue Valves in Symptomatic Severe Aortic Stenosis
Mohammed Salem, Robert Henderson, Kamran Baig, Ian Mitchel, S. Naik,
Thomas Mathew
Nottingham University Hospital, Nottingham, United Kingdom
Background: The design and ﬂow proﬁle of transcatheter aortic valve (TAVI) is
different from surgical prosthetic valve. We compared the post implantation echo-
cardiographic aortic valve gradient of patients undergoing TAVI using Edwards Sa-
pien in our institution to that of surgically implanted bioprosthetic valves (SAVR)
using St Jude Epic, Hancock and Mitrﬂow valves during the same period.
Methods: Consecutive patients who underwent TAVI between January 2010 and May
2011 were included. Patients who underwent SAVR for native aortic stenosis (AS)
were identiﬁed from our database and patients who completed at least one follow up
transthoracic echocardiogram (TTE) were included for ﬁnal analysis. The last per-
formed TTE was included for analysis in both groups.
Results: Thirty six patients underwent TAVI valves between January 2010 and May
2011 and TTE data were available for 34 patients who were included for ﬁnal analysis.
Seventy two patients underwent SAVR with a bioprosthetic valve during the same
period and TTE data were available for 30 patients who were included for ﬁnal
analysis. Mean age (TAVI 83.4
Conclusion: Our initial results suggest excellent early haemodynamic performance of
Edwards Sapien TAVI valve compared to the commonly used surgical bio prosthetic
valves. TTE gradients were lower in the TAVI group than the surgical group but this
requires conﬁrmation in a large prospective patient series. Haemodynamically non-
signiﬁcant aortic regurgitation was signiﬁcantly more common in the TAVI group.
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Background: Rheumatic fever and subsequent Rheumatic heart disease is still widely
prevalent in many of Asian and African countries. Rheumatic heart disease causes
major morbidity and mortality in younger population in such highly prevalent areas.
Juvenile mitral stenosis in age group < 20 years varies uniquely from adult Rheumatic
heart disease. Juvenile mitral stenosis often present with morphologically more ﬁbrous
valve tissue, severe subvalvular disease and less incidence of valve calciﬁcation. Pul-
monary arterial hypertension is more common in this subgroup. Balloon Mitral val-
votomy in Juvenile mitral stenosis has its own limitation due to underlying unsuitable
anatomy of the mitral valve with more of subvalvular fusion and thus result in unsat-
isfactory outcomes. Moreover dedicated hardware for the size of this age group is not
widely available. In this study we analysed the safety and efﬁcacy of Balloon mitral
valvotomy in 329 patients of Juvenile mitral stenosis.
Methods: This retrospective study analysed 329 patients of Juvenile mitral stenosis who
underwent balloon mitral valvotomy in our centre from 1997 to 2011.The age group
ranged from 8 to 20 years with 162 males and 167 females. All patients underwent
detailed pre procedure echocardiographic assessment for suitability of balloon mitral
valvotomy. Left ventricular angiography in RAO view was used to compliment sub-
valvular disease assessment. Balloon mitral valvotomy was done by inoue technique.
Transeptal septal puncture was done with brokenborough needle assembly with ﬂuoro-
scopic guidance. Detailed echocardiofram was performed immediately after the balloon
dilatation . The safety of procedure is assessed by complication incurred during it. Known
complications of Balloon mitral valvotomy like pericardial effusion, cardiac tamponade,
Acute mitral regurgitation, arrhythmias and local vascular complications are noted.
The efﬁcacy of the procedure identiﬁed by achievement of mitral valve area > 1.5 cm2
without development of >grade 2 mitral regurgitation. Also > 50% reduction in mean
left atrial pressure was used as an additional surrogate marker of successful procedure.
Results: Out of 329 patients of Juvenile mitral stenosis 94.3% of patients technically
underwent the procedure completely. No sex predliction found in juvenile mitral
stenosis.3.6% of patients had failed transeptal puncture due to abnormal anatomy of
interatrial septum and 2.1% had subsequent failed left ventricular entry of balloon. For
commisurotomy Inoue balloon was used in 80.84% of cases, cribier commisurotome
device in 3.34% of cases and double balloon, Mansﬁeld balloon and combination in
fewer patients. Majority of patients had single balloon dilatation of stenotic mitral
valve, while 11% had serial balloon dilatations with upsizing, for unyielding valve
morphology.9.1% of patient developed acute mitral regurgitation and out of this 1.5%
had severe mitral regurgitation warranting emergency mitral valve replacement.
Pericardial effusion and Cardiac tamponade occurred in 2.4% of cases and was
managed accordingly. Simple arrthymias noted in 0.6% and local vascular compli-
cation was encountered in 1.2% of cases. one patient had cardiac arrest during pro-
cedure who was successfully resuscitated. No mortality was reported. Overall 7.5% of
cases had encountered procedure related complication.
Procedure was deﬁned successful in 65.95% of cases with good valve area and no
signiﬁcant mitral regurgitation and also without any complications. Signiﬁcant left
atrial pressure reduction was achieved in 65% of cases and < 50% reduction in
pressure was noticed in 16.7% of cases.4.86% of patients had very unyielding valve
despite serial balloon dilatation.
Conclusion: Balloon mitral valvotomy is still largely used as a deﬁnitive ther-
apy,palliative therapy and bridge to surgery in juvenile mitral stenosis.The Nature of
the disease and underlying anatomy of valve grossly determine the successful outcome
of the procedure in this subgroup. Balloon mitral valvotomy is deﬁnitely safe and
relatively efﬁcacious procedure in treating Juvenile mitral stenosis.April 22–25, 2014 j TCTAP Abstracts/ORAL/Valvular Heart Disease
